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The E1 and E2 proteins encoded by papillomaviruses are required for viral replication. Earlier studies have shown that the
viral E2 protein plays an important role in replication by targeting the E1 helicase to the origin of replication (ori). We have
previously shown that the E1 protein of human papillomavirus (HPV) type 1 is sufficient for the in vivo replication of ori
plasmids, although the E2 protein stimulates replication. In this study, we have further analyzed the role of the E2 protein in
HPV-1 replication. The optimal ori of HPV-1 contains one putative E1 binding site (E1BS) and two putative E2 binding sites,
E2BS-3 and E2BS-4. Plasmid pori171, containing the optimal ori, replicates to much higher levels than plasmid pori312, which
includes an additional upstream E2 binding site, E2BS-2, located 75 nucleotides upstream of E2BS-3. To study the possible
role of E2BS-2 and other upstream sequences in E2-dependent downregulation of replication, transient replication analysis
was done in the presence of increasing levels of the E2 protein. Interestingly, inhibition of pori312 replication was more
severe at higher levels of E2, suggesting that this protein may also negatively regulate HPV-1 replication. Deletion of
sequences from pori312 containing an additional putative E2BS, E2BS-2A, relieved the repression of replication to a
significant extent, while replacement of E2BS-2 with a different sequence of the same length had a modest effect. These
results suggest that E2BS-2A plays a major and E2BS-2 a minor role in the negative regulation of HPV-1 replication at high
E2 levels. Electrophoretic mobility-shift assays showed that the purified E2 protein bound with high affinity to E2BS-3 and
weakly to the other putative E2BSs located within the viral long control region. EMSA using various ori fragments showed
the formation of multiple E2–DNA complexes which likely represent binding of E2 to multiple E2BSs present within the HPV-1
ori. Our data are consistent with the assembly of ori–protein complexes at high E2 levels that are impaired for replication and
further suggest that E2 may regulate HPV-1 replication by a mechanism involving interaction between the E2 protein bound
to E2BSs at a distance. © 2001 Academic Press
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SINTRODUCTION
Human papillomaviruses (HPVs) are small (;8 kb),
double-stranded DNA viruses that display strict epithelial
tropism and are subdivided according to epithelial tissue
specificity and pathological affects associated with their
infection. HPVs associated with cutaneous tissue, such
as types 1, 2, and 3, cause plantar and palmar warts,
whereas mucosal HPVs such as types 6, 11, 16, and 18
are associated with either benign or malignant growth of
the infected tissue (zur Hausen and de Villiers, 1994).
Cutaneous HPVs have been shown to produce high
levels of viral DNA and virions, whereas mucosal HPVs
are associated with much lower viral DNA and virion
levels (Oriel and Almeida, 1970; Taichman et al., 1983).
Replication of papillomaviruses requires the viral E1 and
E2 proteins (Chow and Broker, 1994; Lambert, 1991; Sten-
lund, 1996; Ustav and Stenlund, 1991). The E1 protein is
an ;68-kDa nuclear phosphoprotein which has origin
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214(ori) binding, ATPase, helicase, and DNA unwinding ac-
tivities (Mansky et al., 1997; Sedman and Stenlund, 1998;
eo et al., 1993b; Stenlund, 1996; Wilson and Ludes-
Myers, 1991; Yang et al., 1993). Although E1 is the repli-
cation initiator protein, in most cases initiation of repli-
cation also requires the E2 protein (Chiang et al., 1992;
Del Vecchio et al., 1992; Frattini and Laimins, 1994a;
opalakrishnan and Khan, 1994; Riese et al., 1990; Sed-
an and Stenlund, 1995; Seo et al., 1993a; Sverdrup and
han, 1994; Ustav and Stenlund, 1991; Ustav et al., 1993;
ang et al., 1991). The E2 protein is an ;48-kDa nuclear
hosphoprotein which serves as a transcriptional acti-
ator as well as repressor of viral promoters (Fuchs and
fister, 1994; Hawley-Nelson et al., 1988; McBride et al.,
1989, 1991; Prakash et al., 1992). The E2 protein exists as
a dimer and binds to palindromic ACCGN4CGGT se-
uences with high affinity and to ACCN6GGT or its vari-
nts with low affinity (Brokaw et al., 1996; Chow and
roker, 1994; Fuchs and Pfister, 1994; Grossel et al.,
996; Hawley-Nelson et al., 1988; Hegde et al., 1992; Lim
t al., 1998; McBride et al., 1991; Monini et al., 1991;
palholz et al., 1988; Winokur and McBride, 1992). The E1
and E2 proteins form a complex, which binds to the ori,
that includes one E1 binding site (E1BS) and several
E2BSs (Berg and Stenlund, 1997; Bonne-Andrea et al.,
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215REGULATION OF HPV-1 REPLICATION1997; Chow and Broker, 1994; Frattini and Laimins,
1994a,b; Gillette et al., 1994; Mohr et al., 1990; Stenlund,
996; Winokur and McBride, 1996; Yang et al., 1991). The
1BS consists of an imperfect 18-bp palindromic se-
uence that is only partially conserved among various
Vs (Holt et al., 1994). The E2 protein is believed to target
1 to the ori, thereby stimulating initiation of replication.
Previous studies with HPV-1 have shown that the viral
1 protein is sufficient for in vivo replication, although
eplication is significantly increased in the presence of
he E2 protein (Gopalakrishnan and Khan, 1994; Go-
alakrishnan et al., 1995). The HPV-1 ori is contained
ithin the long control region (LCR) of the viral genome
nd contains one putative E1BS and four putative E2BSs,
amely E2BS-1, E2BS-2, E2BS-3, and E2BS-4 (Chow and
roker, 1994; Gopalakrishnan and Khan, 1994; Myers et
l., 1994). The E2BS-3 and E2BS-4 are located adjacent
o the E1BS, and together these elements constitute the
ptimal ori of HPV-1, ori171 (Gopalakrishnan and Khan,
994). The E2BS-2 is located 75 bp upstream of the
2BS-3. We have previously shown that plasmids either
ontaining the entire HPV-1 LCR (pUCLCR-1) or lacking
he E2BS-1 (pori312) replicate to similar levels in the
resence of the HPV-1 E1 and E2 proteins, suggesting
hat E2BS-1 does not play a significant role in replication.
urthermore, these plasmids replicate to lower levels
han plasmid pori171, which contains E1BS, E2BS-3, and
2BS-4 but lacks E2BS-1 and E2BS-2 (Gopalakrishnan
nd Khan, 1994).
In this study, we have investigated the role of the E2
rotein and E2BSs in the regulation of HPV-1 replication.
sing a transient replication assay, we have studied
1-dependent HPV-1 ori replication in the presence of
arying levels of an E2-expressing plasmid. Our results
how that replication of all ori plasmids is inhibited at
igher E2 levels, indicating that it may be involved in the
egative regulation of HPV-1 replication. Our results also
emonstrate that E2-mediated inhibition of replication is
ore severe with plasmids that contain the newly iden-
ified E2BS-2A as well as E2BS-2, suggesting that these
ites are important for this inhibition. Using electro-
horetic mobility-shift assay (EMSA), we demonstrate
hat the purified E2 protein binds to the four previously
ostulated E2BSs, as well as the newly identified E2BS-
A. Our results show that the E2 protein binds with
ighest affinity to E2BS-3, which resembles the high-
ffinity sequence motif ACCGN4CGGT, and this binding
site is involved in E2-mediated upregulation of HPV-1
replication. When EMSAs were performed with various
ori constructs containing different numbers of E2BSs,
unique high-molecular-weight protein–DNA complexes
were obtained that were dependent upon both the pres-
ence of additional E2BSs and higher levels of the E2
protein. Our results suggest that in addition to its positive
role in HPV-1 replication, the E2 protein may also be pinvolved in negative regulation of replication mediated by
E2BSs located at a distance from the core ori region.
RESULTS
E2 protein regulates replication of HPV-1 ori plasmids
We tested the role of the E2 protein in E1-dependent
HPV-1 replication using two plasmids, pori171 and po-
ri312. Plasmid pori171 contains the E1BS and two adja-
cent E2 binding sites, E2BS-3 and E2BS-4 (Fig. 1).
E2BS-3 is a previously postulated high-affinity site having
the motif ACCGN4CGGT, whereas E2BS-4 is a putative
low-affinity site and a variant of the ACCN6GGT motif.
Plasmid pori312 consists of pori171 sequences and, in
addition, contains two putative low-affinity E2 binding
sites (the previously postulated E2BS-2 and the E2BS-2A
identified in this study). These two plasmids were trans-
fected into C-33A cells along with 3 mg of the pSGE1
plasmid expressing the HPV-1 E1 protein and various
amounts of pSGE2 expressing the E2 protein. Both the
pori171 and the pori312 plasmids replicated to low levels
in the presence of pSGE1 alone, and their replication
was significantly stimulated in the presence of low levels
of pSGE2 (Fig. 2). It should be noted that in our transient
replication assays, the ori bands in DpnI-treated lanes
usually represent about 95% of the DNA that is present in
samples untreated with this enzyme (Fig. 2; Gopalakrish-
nan and Khan, 1994; Gopalakrishnan et al., 1999). Thus,
vast majority of the Hirt DNA fraction isolated 3 or 4
ays posttransfection represents replicated DNA while
he unreplicated input DNA is essentially lost from the
ells. Interestingly, replication of pori312 was severely
nhibited at high E2 levels, while only limited inhibition
as observed with pori171 (Fig. 2). These results
howed that although E2 stimulates the replication of ori
FIG. 1. Organization of the HPV-1 LCR containing the ori and the
various ori constructs used in this study. The locations of the E1 and E2
binding sites are indicated by ovals and rectangles, respectively. Num-
bers indicate the nucleotide coordinates of the HPV-1 genome (Myers
et al., 1994; Palermo-Dilts et al., 1990) following the convention used for
other HPVs. E1BS, E1 binding site; E2BS, E2 binding site; P and I
represent perfect and imperfect consensus sequences of E2BSs, re-
spectively. LCR, long control region.lasmids at low levels, high levels of the E2 protein may
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216 VAN HORN, SHEIKH, AND KHANnegatively regulate HPV-1 replication. Furthermore, the
region upstream of E2BS-3, which includes the putative
E2BS-2A and E2BS-2, is involved in this regulation.
Increased levels of the E2 protein do not affect E1
levels
To rule out the possibility that increased levels of the
pSGE2 plasmid were inhibiting replication indirectly by
reducing the expression of the E1 protein in cotransfec-
tion assays, we made use of two plasmids that express
the HPV-1 E1 and E2 proteins as fusions with the FLAG
epitope, utilizing the pSG5 vector used for the expression
of the wild-type E1 and E2 proteins. Transient replication
activities of the FLAG-E1 and FLAG-E2 proteins were
found to be indistinguishable from those of the respec-
tive wild-type proteins (data not shown). We cotrans-
fected 3 mg of the FLAG-E1-expressing plasmid and
arious amounts of the FLAG-E2-expressing plasmid into
-33A cells. Western blot analysis of cell lysates showed
hat the levels of the FLAG-E1 protein were not signifi-
antly affected in the presence of higher levels of the
SGE2 plasmid (Fig. 3).
2BS-2A plays a major role in E2-mediated
epression of HPV-1 DNA replication
Plasmid pori312 includes a 175-bp region upstream of
2BS-3 from HPV-1 which is absent in pori171 (Fig. 1).
his region includes the putative E2BS-2 (HPV-1 nt 7701–
712) and E2BS-2A (HPV-1 nt 7625–7636). Since the E2
FIG. 2. Transient replication analysis of pori171 and pori312 in the pr
of pSGE1 and 0.5 mg of the pori171 or pori312 plasmid were transfected
SG5 vector was added so that each sample was transfected with a to
with DpnI. Positions of the pori171 and pori312 plasmids (pori) are ind
various samples as measured by using a Molecular Dynamics phosphrotein inhibited pori312 replication to a much greaterxtent than that of pori171, we wished to determine
hether E2BS-2, E2BS-2A, and/or the intervening se-
uence between E2BS-2A and E2BS-3 is involved in the
egulation of HPV-1 replication. We generated plasmid
ori267, which is similar to pori312, except that it lacks
he putative E2BS-2A (Fig. 1). Transient replication of
ori267 was studied in competition with pori171 and
ori312 in the presence of fixed amounts of pSGE1 and
ncreasing amounts of pSGE2 (Figs. 4A and 4B). When
ested in competition with pori312, pori267 replicated
ore efficiently regardless of the E2 protein levels and
ts replication was inhibited to a moderate degree at high
2 levels compared to that of pori312, which was se-
erely repressed (Fig. 4A). These results suggest that
2BS-2A plays a major role in E2-mediated repression of
of various amounts of the E2-expressing plasmid. Three micrograms
-33A cells along with the indicated amounts of pSGE2. Empty plasmid
.5 mg of DNA. The samples were either not treated (2) or treated (1)
The graph at the bottom shows the amount of radioactivity present in
er (shown as volume).
FIG. 3. Western blot analysis of FLAG-E1 and FLAG-E2 in transfected
C-33A cells. Three micrograms of the pSG(F2)-E1 plasmid expressing
FLAG-E1 and the indicated amounts of the pSG(F2)-E2 plasmid ex-
pressing FLAG-E2 were cotransfected into C-33A cells. Two days
posttransfection, the protein lysates were subjected to SDS–PAGE andesence
into C
tal of 8
icated.Western blot analysis using the anti-FLAG M2 monoclonal antibody.
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217REGULATION OF HPV-1 REPLICATIONreplication. Plasmid pori267 replicated to levels similar
to those of pori171 in the presence of lower amounts of
pSGE2 (Fig. 4B). However, repression of pori267 replica-
tion was greater than that of pori171 at higher E2 levels
(Fig. 4B), suggesting that E2BS-2 and/or the intervening
sequence between E2BS-2A and E2BS-3 may also play a
role in E2-mediated regulation of HPV-1 replication. To
test the significance of E2BS-2 in the regulation of HPV-1
replication, E2BS-2 was replaced with the NotI restriction
endonuclease recognition site to generate plasmid
pori312mut7701–7712 (pori312mut) (Fig. 1). When tested
in a competition assay, replications of pori312 and
pori312mut were comparable at lower levels of E2 (Fig.
5). However, in the presence of higher levels of E2,
replication of pori312 was inhibited to a moderately
higher extent than that of pori312mut in three indepen-
ent experiments. These results suggest that E2BS-2
ay also contribute to E2-mediated regulation of HPV-1
eplication. Note that since pori312 and pori312mut are
dentical in size, the NotI enzyme was used to generate
slightly smaller DNA fragment from the mutant plasmid.
inding of E2 protein to the various E2 binding sites
resent within the viral LCR
Previous studies with other PV E2 proteins have sug-
ested that the sequence ACCGN4CGGT corresponds to
high-affinity E2BSs while the sequence ACCN6GGT rep-
resents low-affinity E2BSs. Based on this, the previously
postulated E2BSs within the HPV-1 LCR were predicted
FIG. 4. E2BS-2A is inhibitory for HPV-1 replication. Transient replic
ndicated amounts of pSGE2. (A) Transient replication of pori267 com
combination with pori171 (0.5 mg each). To separate pori267 from pori17
ith BamHI. This treatment linearizes pori171 and pori312, but releases
wo plasmids. The graphs on the sides show the amount of radioactiv
maging detector.to be of high affinity (E2BS-3, ACCGAATTCGGT) or lowaffinity (E2BS-2, ACCTAAAACGGT). The putative E2BS-1
(ACCGCACCCGTT) and E2BS-2A (GCCAACCGCGGT) are
variants of the low-affinity site, while E2BS-4 (ACCTAG-
GAGTT) differs substantially from the E2BS consensus
sequence. The high-affinity E2BS-3 is located adjacent to
the putative E1BS and is critical for stimulation of repli-
cation by the E2 protein (Gopalakrishnan and Khan,
1994). To study the binding of the E2 protein to the
nalysis was carried out in C-33A cells using 3 mg of pSGE1 and the
to that of pri312 (0.5 mg each). (B) Transient replication of pori267 in
pori312 DNAs in the above experiments, the Hirt fractions were treated
-bp fragment from pori267 DNA that makes it run faster than the other
ent in various samples as measured by using an Ambis radioanalytic
FIG. 5. Deletion of E2BS-2 partially relieves E2-mediated repression
of pori312 replication. One-half microgram each of the pori312 and
pori312mut DNA was used in transient replication analysis. The graph
at the bottom shows the amount of radioactivity present in various
samples as measured by using a Molecular Dynamics phosphorim-ation a
pared
1 and
a 275
ity presager (shown as volume).
e
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218 VAN HORN, SHEIKH, AND KHANputative E2BSs present within the HPV-1 LCR, EMSAs
were performed. Incubation of a 115-bp labeled restric-
tion fragment containing only the E2BS-3 with the
FLAG-E2 protein generated a single DNA–protein com-
plex, C1 (Fig. 6). This complex presumably corresponds
to the binding of one E2 dimer to the E2BS-3. To compare
the relative binding affinity of the HPV-1 E2 protein to the
various E2BSs present in the HPV-1 LCR, competition
experiments were performed in which increasing
amounts of cold E2BSs were added to the reactions. The
competitors consisted of synthetic oligonucleotides con-
taining the various putative E2BSs and the surrounding
9-bp sequence on either side. E2BS-3 was found to be
the most efficient competitor and disrupted the formation
of the C1 at all the concentrations used (Fig. 6). The other
putative E2BSs were able to compete effectively only at
higher concentrations. The C1 complex was not signifi-
cantly affected in the presence of an excess of the
nonspecific NotI oligonucleotide. The above results con-
firmed that E2BS-3 represents a high-affinity E2BS while
the other E2BSs have a lower affinity for binding to the E2
protein.
FIG. 6. Binding of the HPV-1 E2 protein to the E2BS-3. A 32P-labeled re
ither with no competitor oligonucleotide (0) or with 80-, 800-, and 8
esolved on a 1.2% agarose gel. C, DNA–protein complex; F, free prob
FIG. 7. Binding of the HPV-1 E2 protein to various ori subregions. 32P
either 20 or 100 ng of the FLAG-E2 protein and the DNA–protein compl
and the C1 and C2 complexes obtained in the presence of this DNA a
the right: F, free ori fragments; C1, C2, C3, and C4, the various ori–E2 compleBinding of the HPV-1 E2 protein to various ori
subregions
In an effort to further investigate the binding of the E2
protein to the HPV-1 ori, EMSAs were performed with
various ori regions that were used in transient replication
assays. The ori171 DNA fragment containing the high-
affinity E2BS-3 and the low-affinity E2BS-4 generated a
single major band, C1, at low E2 concentrations, which
presumably corresponds to one E2 dimer bound to
E2BS-3 (Fig. 7). This postulate is supported by the ob-
servation that a single C1 complex was also observed
with a restriction fragment containing E2BS-3 alone (Fig.
6). A minor, faster migrating band in Fig. 7 likely repre-
sents DNA binding by trace amounts of an E2 degrada-
tion product which may harbor the E2 DNA-binding do-
main. At higher E2 levels, a larger DNA–protein complex,
C2, was generated which probably corresponds to the
binding of E2 dimers to both the E2BS-3 and the E2BS-4
(Fig. 7). When ori fragments harboring additional E2BSs
were used, only the C1 complex was observed at low E2
levels (Fig. 7). Again, this presumably represents binding
n fragment harboring E2BS-3 was incubated with the FLAG-E2 protein
d excess of the indicated E2BSs. The DNA–protein complexes were
restriction fragments containing different E2BSs were incubated with
solved on a 1.2% agarose gel. The positions of the free ori171 DNA (F)
wn on the left. The positions of the other ori fragments are shown onstrictio
000-fol-labeled
exes re
re shoxes.
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219REGULATION OF HPV-1 REPLICATIONof the E2 protein to the high-affinity E2BS-3. At higher E2
levels, larger DNA–protein complexes (C2, C3, and C4)
were also generated. These complexes are likely to
correspond to the occupation of two, three, and four
E2BSs, respectively, by the E2 protein. The above results
confirmed that within the context of the genetically de-
fined HPV-1 ori, E2BS-3 represents the strongest E2BS
while the other E2BSs are low-affinity sites that bind to
the E2 protein when it is present at higher levels.
DISCUSSION
Replication of most PVs requires the E1 and E2 pro-
teins and an origin of DNA replication. Although the E2
protein plays multiple roles in replication, a major func-
tion of this protein is to target E1, which is a weak DNA
binding protein, to the ori (Chow and Broker, 1994; Frat-
tini and Laimins, 1994a; Sedman and Stenlund, 1995; Seo
et al., 1993a; Stenlund, 1996; Ustav et al., 1993; Winokur
nd McBride, 1992). In this study, we investigated the
ole of the E2 protein and E2BSs in the regulation of
PV-1 replication. Plasmid pori312 replicated to lower
evels compared to pori171 in the presence of various
mounts of the E2-expressing plasmid, and its replica-
ion was drastically reduced at the highest E2 levels (Fig.
). This was not due to reduced expression of the E1
rotein at higher E2 levels as demonstrated by Western
lot analysis (Fig. 3). The replication of pori171 was also
epressed at high E2 levels although to a more modest
egree compared to that of pori312. At low levels, the E2
rotein stimulated replication of both the pori171 and the
ori312 plasmids (Fig. 2). Since plasmids pori171 and
ori312 replicate to similar levels in the presence of the
1 protein alone (Fig. 2 and Gopalakrishnan and Khan,
994), our results demonstrate that the E2 protein is both
positive and a negative regulator of HPV-1 replication.
he E2-mediated inhibition of replication is not due to
oxicity, since overexpression of E2 is not toxic to C-33A
ells (Dowhanick et al., 1995). Furthermore, E2 does not
nhibit replication of ori plasmids lacking the E2BSs (un-
ublished data). Since plasmid pori312 replicates to lev-
ls similar to those of the pUCLCR-1 plasmid containing
he full HPV-1 LCR in the presence of E2 (Gopalakrishnan
nd Khan, 1994), these results suggest that E2 is capable
f downregulating replication in the context of the normal
ri. Since replication of pori312 was more severely inhib-
ted than that of pori171 at high E2 levels, plasmid po-
i267 was used to study the role of E2BS-2A and E2BS-2
n E2-dependent regulation. Plasmid pori267 replicated
o much higher levels than pori312 in replication compe-
ition assays at all the E2 levels tested (Fig. 4A). These
esults suggest that E2BS-2A plays a major role in E2-
ediated inhibition of HPV-1 replication. However, repli-
ation of pori267 was lower than that of pori171 at higher
2 levels (Fig. 4B), suggesting that the region between
2BS-2A and E2BS-3 (which includes E2BS-2) is also Tmportant in E2-dependent inhibition. To test whether
2BS-2 contributes to E2-mediated inhibition of HPV-1
eplication, this binding site was replaced with a se-
uence of the same length that included a NotI site to
enerate plasmid pori312mut7701–7712 (Fig. 1). Plas-
ids pori312 and pori312mut7701–7712 replicated to
imilar levels in the presence of lower amounts of the
2-expressing plasmid, while the repression of replica-
ion at high E2 levels was partially relieved when E2BS-2
as exchanged with the NotI sequence (Fig. 5). Taken
ogether, the above observations suggest that E2BS-2A
nd E2BS-2 located upstream of the optimal ori se-
uence do not have a stimulatory role in HPV-1 replica-
ion. Rather, these sites are involved in E2-mediated
epression of replication in which E2BS-2A plays a major
nd E2BS-2 a minor role.
The E2BSs within the HPV-1 LCR were previously
ssigned based on the PV E2 consensus binding se-
uence. EMSA showed that a DNA fragment containing
he E2BS-3 bound to the E2 protein efficiently (Fig. 6). The
ther putative E2BSs located in the HPV-1 LCR were also
ound to represent true E2BSs based on their ability to
ompete with the binding of the E2 protein to the E2BS-3
Fig. 6). The individual E2BSs were also found to bind to
he E2 protein directly in EMSA (data not shown). Since
he E2 protein of other PVs binds to the DNA as a dimer
Brokaw et al., 1996; Chow and Broker, 1994; Fuchs and
fister, 1994; Grossel et al., 1996; Hawley-Nelson et al.,
988; Hegde et al., 1992; Lim et al., 1998; McBride et al.,
991; Monini et al., 1991; Spalholz et al., 1988; Winokur
nd McBride, 1992), we assume that this is also the case
or the HPV-1 E2 protein. Our EMSA results in the pres-
nce of competitor E2BSs showed that E2BS-3 has the
ighest affinity for the E2 protein since cold E2BS-3 was
ble to totally compete away the binding at the lowest
oncentration, while the other E2BSs competed well only
t higher concentrations (Fig. 6). The above conclusion is
urther supported by the results of EMSA using various
ri restriction fragments. In these experiments, only the
1 complex representing the binding of E2 to E2BS-3
as observed at low E2 concentrations (Fig. 7). At higher
2 levels, additional DNA–protein complexes were also
bserved (Fig. 7). The C2, C3, and C4 complexes pre-
umably represent E2 dimers bound to the lower affinity
2BSs present within the ori, in addition to the high-
ffinity E2BS-3. In EMSA, generally the number of DNA–
rotein complexes observed corresponded to the num-
er of E2BSs present in the ori fragments. For example,
ri171, ori267, and ori312, containing two, three, and four
2BSs, respectively, generated a corresponding number
f DNA–protein complexes (Fig. 7). Furthermore, a DNA
ragment containing only the E2BS-3 generated only one
NA–protein complex (Fig. 6). Also, the C4 complex
bserved with ori312 was not detected with ori260, which
s similar to ori312 except that it lacks E2BS-4 (Fig. 7).
he only exception to this rule was the presence of faint
ext for
220 VAN HORN, SHEIKH, AND KHANC4 complexes with ori267 and ori312mut DNAs, which
contain three E2BSs (Fig. 7). The reason for this obser-
vation is not clear, and it is possible that E2 may bind
weakly to another sequence in the upstream region of
the ori. Since E2-mediated regulation of HPV-1 replica-
tion is more severe in the presence of the upstream
E2BSs that are absent in ori171, the above results are
consistent with the possibility that some of the larger
DNA–protein complexes that assemble in the context of
the complete HPV-1 ori (or LCR) may be impaired for
replication. Replication of pori171 is also repressed at
high E2 levels, although only to a modest degree (Fig. 2).
This inhibition may be caused by an increase in the
occupancy of E2BS-3 and E2BS-4 by E2 dimers, which
may interfere with the assembly of an E1–E2–ori complex
at the ori. It should be noted that the E2 protein is
expected to target E1 to the ori during the initiation of
HPV-1 replication, and the nature of E1–E2–ori com-
plexes may also be altered depending upon the relative
levels of the E2 protein. Future biochemical analysis
utilizing both the E1 and the E2 proteins should identify
the nature of DNA–protein complexes that assemble
during the initiation of HPV-1 replication as well as the
mechanism of E2-mediated repression.
It is known that low levels of the E2 protein are suffi-
cient to target E1 to the ori of PVs, and binding of E2 to
adjacent E2BSs is a cooperative event that enhances
E2-mediated stimulation of E1-dependent PV replication
(Hawley-Nelson et al., 1988; Hegde et al., 1992; McBride
and Howley, 1991; McBride et al., 1991; Monini et al.,
1991; Spalholz et al., 1988; Winokur and McBride, 1996).
Results presented here as well as our previously pub-
lished studies (Gopalakrishnan and Khan, 1994) have
shown that E2 significantly stimulates HPV-1 replication
at low levels and requires both E2BS-3 and E2BS-4
located within the optimal ori for this stimulation. The E2
protein of BPV-1 has been shown to cause DNA bending
and mediates looping of the DNA when E2BSs are sep-
arated by a distance (Chen and Stenlund, 2000; Hegde et
al., 1992; Knight et al., 1991; Moskaluk and Bastia, 1988).
FIG. 8. A model for the regulation of HPV-1 replication at high levels
and the E2 protein as a dimer based on studies with other PVs. See tOur results have shown that deletion of E2BS-2A frompori312 results in a significant loss of E2-mediated re-
pression of replication (Figs. 4A and 4B). Furthermore,
removal of E2BS-2 within the context of pori312 also has
a modest effect on this repression (Fig. 5). The E2BS-2A
and E2BS-2 lie 150- and 75-bp upstream of E2BS-3,
respectively, placing the three E2BSs approximately
seven helical turns from one another in phase (Fig. 1).
Based on prior studies with PV E2 proteins and our
results, we postulate a model based on E2-mediated
assembly of a replication-impaired DNA–protein com-
plex at the HPV-1 ori (Fig. 8). In the presence of low levels
of the E2 protein, E2 efficiently targets E1 to the ori and
an E1–E2 complex assembles at the optimal HPV-1 ori
that includes the E1BS, E2BS-3, and E2BS-4. As postu-
lated for other PVs, it is possible that this complex serves
as a precursor for an E1–ori complex that is competent
for the initiation of replication (Chen and Stenlund, 2000,
2001). At higher E2 levels, the upstream E2BS-2A and
E2BS-2 that we have shown to be required for E2-medi-
ated repression of replication may also be occupied by
the E2 protein. Since these binding sites are located at a
substantial distance from the optimal ori present in
ori171, E2 dimers bound to these upstream sites are
unlikely to be in direct contact in a linear manner on the
DNA. Rather, it is more likely that the E2 protein bound to
these sites may promote bending and/or looping of the
DNA, which could result in the formation of an E1–E2–ori
(or E2–ori) complex that is impaired in replication (Fig. 8).
Some of the slower migrating bands observed in Fig. 7
may correspond to such complexes. Initiation of replica-
tion from an E1–E2–ori complex formed at high E2 levels
may be inefficient for several reasons such as (i) steric
hindrance that interferes with the recruitment of cellular
replication factors to the ori, (ii) retention of E2 in the
initiation complex at the ori from which it is normally
displaced (Berg and Stenlund, 1997; Gillette and
Borowiec, 1998; Lusky et al., 1994; Sedman and Stenlund,
1995; Stenlund, 1996), (iii) lack of assembly of an appro-
priate E1 oligomer at the ori, or (iv) binding of free E2 to
the E2BSs which may inhibit binding of the E1–E2 com-
E2 protein. The active form of the E1 protein is shown as a hexamer
details.of theplex to the ori; this possibility is especially likely in the
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221REGULATION OF HPV-1 REPLICATIONcase of pori171, which lacks both E2BS-2A and E2BS-2.
For example, at high E2 levels more E2 dimers are likely
to be present compared to E1–E2 complexes. It is pos-
sible that under these conditions E2 may bind indepen-
dently to E2BS-3 and E2BS-4, thereby excluding the for-
mation of an E1–E2–ori complex. This would result in an
inhibition of replication.
Since the E2 protein negatively regulates transient
replication of HPV-1, it is possible that it may also play a
similar role during the HPV-1 life cycle. Following infec-
tion of the basal epithelium, the HPV genome is estab-
lished at a fixed copy number of 50–100 per cell and viral
replication occurs in the S phase of the cell cycle (Lam-
bert, 1991). As basal cells terminally differentiate, a
switch from regulated to productive replication occurs,
and the copy number of the HPV genome increases
significantly. The exact mechanism involved in this
switch remains unknown. It is possible that different
E1/E2 ratios during terminal differentiation of epithelial
cells may play a role in both upregulation of HPV-1
replication and inhibition of possible runaway replica-
tion.
MATERIAL AND METHODS
Plasmids and cell line
Plasmids pSGE1 and pSGE2 expressing the HPV-1 E1
and E2 proteins from the SV40 early promoter have been
described (Gopalakrishnan and Khan, 1994). Plasmids
pSG(F2)-E1 and pSG(F2)-E2 expressing the HPV-1 E1
and E2 proteins as N-terminal fusions with the FLAG
peptide epitope, respectively, were generated by insert-
ing synthetic oligonucleotides encoding two tandem
copies of the FLAG peptide upstream of the second
codons of the E1 and E2 open reading frames. Plasmids
pori171 and pori312 containing the various HPV-1 ori
subregions have been described previously. C-33A is an
HPV-negative cervical carcinoma cell line (Gopalakrish-
nan and Khan, 1994).
Generation of pori267 and pori312mut7701–7712
Polymerase chain reaction (PCR) was utilized to
generate various ori constructs. Plasmid pori267 was
generated using oligonucleotide primers 59-CCGGATC-
CTAGGACTTGTTTCAATT TGCTGCC-39 (HPV-1 nt posi-
tions 7637 to 7660) with a BamHI linker and 59-GGTAC-
CCGGGGATCCTCTAGAGTC-39 (pUC19 vector positions
08 to 431) using pori312 DNA as template in PCR. The
CR product was digested with BamHI and ligated into
he BamHI site of pUC19 (Sambrook et al., 1989). Plasmid
ori312mut (containing a 12-bp sequence including a
otI site in place of E2BS-2 at HPV-1 positions 7701–
712) was generated using two separate PCRs. Synthetic
ligonucleotides 59-CTGGTACTAATGCGGTTCG-39, com-lementary to pUC19 vector nt 448–467, and 59-ATAA-
AATGCGGCCGCTTGCTTGGCACCAA-39, complemen-
ary to HPV-1 nt 7689 to 7713 with a 59 NotI sequence,
erved as PCR primers using pori312 as the template in
he first reaction. Synthetic oligonucleotides 59-ATAA-
AATGCGGCCGCAAAGGTGTGTACTCTTTTCAAGAATT-
AC-39, complementary to HPV-1 nt 7713 to 7739 with a
9 NotI sequence, and 59-GGCGATTAAGTTGGGTA-
CGCCAGGG-39, complementary to pUC19 nt 334 to 359,
erved as PCR primers using pori312 as a template in the
econd reaction. The PCR product of the first reaction
as digested with NotI and HindIII while the second PCR
roduct was subjected to NotI/BamHI digestion. The two
bove PCR products were then mixed with pUC19 DNA
igested with HindIII and BamHI and the three DNA
ragments ligated in one step using T4 DNA ligase (Sam-
rook et al., 1989). Plasmid pori260 was a spontaneous
eletion.
ransient replication assays
The human cervical carcinoma cell line C-33A was
ransfected with plasmid DNA by calcium phosphate
oprecipitation (Chen and Okayama, 1987). Transient
eplication assays were performed using 8 3 105 cells in
0-mm plates and 3 mg of the E1-expressing plasmid
pSGE1), either 1 mg or the indicated amounts of the
2-expressing plasmid (pSGE2) and 0.5 mg of the ori
plasmids. Empty plasmid pSG5 vector was added to
samples such that each transfection contained the same
amount of total plasmid DNA. In competition replication
assays, 0.5 mg each of the appropriate ori plasmids was
sed. Three to four days posttransfection, low-molecular-
eight DNA was isolated by the Hirt extraction proce-
ure (Hirt, 1967). The samples were first treated with
coRI (unless otherwise indicated) to either linearize or
leave the plasmids into two fragments, one of which
as complementary to the probe. To distinguish be-
ween replicated and unreplicated DNA, one-half of each
ample was then treated with an excess of DpnI to
emove the unreplicated, methylated input DNA. The
NA samples were analyzed by electrophoresis on 0.7%
garose gels using Tris–borate–EDTA buffer followed by
outhern blot hybridization (Sambrook et al., 1989). The
NA was transferred to GeneScreen and the mem-
ranes were hybridized to 32P-labeled pUC19 probe (2–
4 3 107 cpm) generated by using the random primer
labeling kit (Amersham). Specific activity of the probes
typically ranged from 1 3 108 to 1 3 109 cpm/mg of the
DNA. Blots were subjected to autoradiography at 270°C
with intensifying screens. The amount of radioactivity
present in various bands was measured by using either
an Ambis radioanalytic imaging detector or a Molecular
Dynamics phosphorimager.
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The relative levels of the E1 and E2 proteins in trans-
fected C-33A cells were measured by immunoblotting.
Three micrograms of the pSG(F2)-E1 plasmid along with
various amounts of the pSG(F2)-E2 plasmid were co-
transfected into 1 3 106 C-33A cells by calcium phos-
phate coprecipitation. Two days posttransfection, cells
were lysed using 0.25 ml of lysis buffer (50 mM Tris–HCl,
pH 8.0, 150 mM NaCl, 0.02% sodium azide, and 1% Triton
X-100). Protein concentrations in the various samples
were determined by using the Bio-Rad protein assay kit.
Proteins were transferred to Immobilon-P membrane
(Millipore), and FLAG-E1 and FLAG-E2 proteins were
detected using anti-FLAG M2 monoclonal antibody
(Kodak) and goat anti-mouse IgG peroxidase conjugate
(Sigma). The secondary antibody in the conjugate was
detected by using the ECL (enhanced chemilumines-
cence) reagent from Amersham.
Purification of the HPV-1 E2 protein
The HPV-1 E2 protein was purified by overexpression
as a fusion protein with two tandem copies of the FLAG
peptide at its amino-terminal end in insect cells using the
BAC-TO-BAC baculovirus system (Life Technologies,
Gaithersburg, MD). A NotI fragment encoding the
FLAG-E2 protein was isolated from the pSG(F2)-E2 plas-
mid and ligated into the NotI site of the pFASTBAC1
vector. Recombinant baculovirus was isolated by the
procedures recommended by the supplier. Insect Sf-9
cells were infected with the HPV-1 E2 baculovirus at a
multiplicity of infection of 1 and cells harvested after 48 h.
Large-scale cultures of insect cells expressing the HPV-1
E2 protein were obtained from the National Cell Culture
Center (Minneapolis, MN). Two-liter cultures of infected
Sf-9 cells were pelleted and resuspended in Buffer A [20
mM Tris–HCl, pH 8.0, 1.5 mM MgCl2, 10% glycerol, 1 mM
DTT, and Complete protease inhibitor cocktail (Boeh-
ringer Mannheim)] followed by 20 min incubation on ice.
Cells were lysed by Dounce homogenization (20 strokes
of pestle A) and nuclei obtained by centrifugation at 4000
rpm in a Sorval SS34 rotor at 4°C for 5 min. Nuclei were
resuspended in Buffer B (20 mM Tris–HCl, pH 8.0, 300
mM NaCl, 0.25% Triton X-100, 10% glycerol, 1 mM DTT)
followed by sonication (four times for 2 min each at 30-s
intervals). The nuclear lysate was subjected to ultracen-
trifugation in a SW41Ti rotor at 37,000 rpm for 3 h. The E2
protein present in the supernatant was purified by affinity
chromatography using Anti-FLAG M2-Agarose Affinity
Gel (Sigma). After loading the nuclear lysate on the
affinity column, the column was washed with Buffer A
containing 1 M NaCl followed by elution with Buffer A
containing 10 mM FLAG peptide. Presence of the E2
protein in eluted fractions was monitored by Western blot
analysis and the protein concentrated using an Amicon
ultrafiltration cell.Electrophoretic mobility-shift assays
Restriction fragments containing the various subre-
gions of the HPV-1 ori were isolated by double-digestion
of the plasmid DNAs with XmaI and HindIII. Restriction
fragment containing only E2BS-3 used in the competition
experiment was isolated by double-digestion of
pori312mut with NotI and HpaI. Synthetic oligonucleo-
tides (30 nt long) containing the various E2BSs and the
surrounding 9 nt on either side which were used as
competitors were obtained from Life Technologies. The
sequences of the various E2BSs are E2BS-1, ACCGCAC-
CCGTT; E2BS-2A, GCCAACCGCGGT; E2BS-2, ACCTA-
AAACGGT; E2BS-3, ACCGAATTCGGT; E2BS-4, ACCTAG-
GAGTT; and E2BSmut, AAGCGGCCGCAA. One hundred
nanograms of each restriction fragment was dephospho-
rylated with calf intestinal alkaline phosphatase and the
59 ends of the fragments were labeled with 32P using 50
mCi [g-32P]ATP (4500 Ci/mmol) and T4 polynucleotide
inase (Sambrook et al., 1989). DNA binding reactions
ontained 25 mM Tris–HCl, pH 8.0, 7 mM MgCl2, 1 mM
DTT, 5% glycerol (v/v), 25 ng poly(dI–dC), 32P-labeled
restriction fragments, and various amounts of the
FLAG-E2 protein. The reactions were incubated at room
temperature for 20 min and DNA–protein complexes
were resolved by electrophoresis on 1.2% agarose gels
run at 110 V for 6 h using 0.53 TBE buffer (Sambrook et
al., 1989). The gels were dried and subjected to autora-
diography.
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